Equities

Adapthealth Corp

AHCO:NAQ

Adapthealth Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)9.97
  • Today's Change0.08 / 0.81%
  • Shares traded65.34k
  • 1 Year change+17.29%
  • Beta1.1125
Data delayed at least 15 minutes, as of Nov 22 2024 15:52 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments7746150
Total Receivables, Net389359360
Total Inventory114128123
Prepaid expenses695237
Other current assets, total------
Total current assets649585670
Property, plant & equipment, net638622546
Goodwill, net2,7253,5453,513
Intangibles, net130163202
Long term investments------
Note receivable - long term------
Other long term assets212215
Total assets4,5095,2205,250
LIABILITIES
Accounts payable212223248
Accrued expenses16310196
Notes payable/short-term debt000
Current portion long-term debt/capital leases623735
Other current liabilities, total535275
Total current liabilities537456500
Total long term debt2,1172,1572,184
Total debt2,1802,1942,219
Deferred income tax------
Minority interest8.226.604.78
Other liabilities, total388448500
Total liabilities3,0503,0683,189
SHAREHOLDERS EQUITY
Common stock0.010.010.01
Additional paid-in capital2,1502,1302,107
Retained earnings (accumulated deficit)(653)26(43)
Treasury stock - common(43)(14)--
Unrealized gain (loss)------
Other equity, total4.368.69(2.35)
Total equity1,4582,1512,062
Total liabilities & shareholders' equity4,5095,2205,250
Total common shares outstanding133134134
Treasury shares - common primary issue3.940.750
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.